Asymptomatic Erosive Esophagitis.
Du Y, Spencer A, Roy P, Abdulhamid A, Dalessio S, Levenick J, Maranki J, Razjouyan H, Coates MD.
Dig Dis Sci. 2025 Feb;70(2):462-468. doi: 10.1007/s10620-024-08793-z. Epub 2024 Dec 18.
Experimental drugs for erosive esophagitis: what is in the clinical development pipeline?
Simadibrata DM, Lesmana E, Lee YY.
Expert Opin Investig Drugs. 2024 Oct;33(10):1009-1018. doi: 10.1080/13543784.2024.2393868. Epub 2024 Aug 30.
Eosinophilic esophagitis.
Watts MM, Saltoun C, Greenberger PA.
Allergy Asthma Proc. 2019 Nov 1;40(6):462-464. doi: 10.2500/aap.2019.40.4272.
Erosive esophagitis and nonerosive reflux disease (NERD): comparison of epidemiologic, physiologic, and therapeutic characteristics.
Fass R.
J Clin Gastroenterol. 2007 Feb;41(2):131-7. doi: 10.1097/01.mcg.0000225631.07039.6d.
Erosive Esophagitis Portends a Benign Clinical Course in the Majority of Patients.
Bi D, Katzka DA, Lavey CJ, Geno DM, Ravi K.
Dig Dis Sci. 2020 Nov;65(11):3244-3252. doi: 10.1007/s10620-019-06027-1. Epub 2020 Jan 6.
Potassium-Competitive Acid Blocker Suppression of Gastric Acid in Erosive Esophagitis: Is Stronger and Longer Better?
Katzka DA, Kahrilas PJ.
Gastroenterology. 2023 Jan;164(1):14-15. doi: 10.1053/j.gastro.2022.10.022. Epub 2022 Oct 28.
[Esophagoprotective therapy in patients with erosive esophagitis].
Bakulina NV, Tikhonov SV, Topalova YG, Ilchishina TA, Vasiliev RV.
Ter Arkh. 2022 Oct 12;94(8):985-991. doi: 10.26442/00403660.2022.08.201828.
Non-erosive reflux disease (NERD) and erosive esophagitis--a spectrum of disease or special entities?
Fass R.
Z Gastroenterol. 2007 Nov;45(11):1156-63. doi: 10.1055/s-2007-963628.
Randomised phase 3 trial: tegoprazan, a novel potassium-competitive acid blocker, vs. esomeprazole in patients with erosive oesophagitis.
Lee KJ, Son BK, Kim GH, Jung HK, Jung HY, Chung IK, Sung IK, Kim JI, Kim JH, Lee JS, Kwon JG, Park JH, Huh KC, Park KS, Park MI, Kim N, Lee OY, Jee SR, Lee SK, Youn SJ, Kim SK, Lee ST, Hong SJ, Choi SC, Kim TN, Youn YH, Park HJ, Kang MJ, Park CH, Kim BT, Youn S, Song GS, Rhee PL.
Aliment Pharmacol Ther. 2019 Apr;49(7):864-872. doi: 10.1111/apt.15185. Epub 2019 Mar 6.
Erosive esophagitis in asymptomatic subjects: risk factors.
Wang FW, Tu MS, Chuang HY, Yu HC, Cheng LC, Hsu PI.
Dig Dis Sci. 2010 May;55(5):1320-4. doi: 10.1007/s10620-009-0888-z. Epub 2009 Aug 14.
